Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1148

1.

Medical identity theft: prevention and reconciliation initiatives at Massachusetts General Hospital.

Judson T, Haas M, Lagu T.

Jt Comm J Qual Patient Saf. 2014 Jul;40(7):291-5.

PMID:
25130011
[PubMed - in process]
2.

Anti-D prophylaxis: past, present and future.

de Haas M, Finning K, Massey E, Roberts DJ.

Transfus Med. 2014 Feb;24(1):1-7.

PMID:
25121157
[PubMed - in process]
3.

Management and outcome of 35 cases with foetal/neonatal alloimmune neutropenia.

van den Tooren-de Groot R, Ottink M, Huiskes E, van Rossum A, van de Voorn B, Slomp J, de Haas M, Porcelijn L.

Acta Paediatr. 2014 Jul 10. doi: 10.1111/apa.12741. [Epub ahead of print]

PMID:
25039288
[PubMed - as supplied by publisher]
4.

ALK expression is absent in pancreatic ductal adenocarcinoma.

Ormanns S, Assmann G, Reu S, Gallmeier E, Bader DC, Kleespies A, Haas M, Kruger S, Heinemann V, Kirchner T, Boeck S.

J Cancer Res Clin Oncol. 2014 Sep;140(9):1625-8. doi: 10.1007/s00432-014-1774-4. Epub 2014 Jul 14.

PMID:
25017418
[PubMed - in process]
5.

Unmasking a unique glomerular lesion.

VanBeek C, Haas M.

Kidney Int. 2014 Jul;86(1):13-5. doi: 10.1038/ki.2013.557.

PMID:
24978376
[PubMed - in process]
6.

5-OMe-uridine-5'-O-(α-boranodiphosphate), a novel nucleotide derivative highly active at the human P2Y6 receptor protects against death-receptor mediated glial apoptosis.

Haas M, Ginsburg-Shmuel T, Fischer B, Reiser G.

Neurosci Lett. 2014 Aug 22;578:80-4. doi: 10.1016/j.neulet.2014.06.030. Epub 2014 Jun 23.

PMID:
24970757
[PubMed - in process]
7.

Induction of hepatic apolipoprotein A-I gene expression by the isoflavones quercetin and isoquercetrin.

Haas MJ, Onstead-Haas LM, Szafran-Swietlik A, Kojanian H, Davis T, Armstrong P, Wong NC, Mooradian AD.

Life Sci. 2014 Aug 6;110(1):8-14. doi: 10.1016/j.lfs.2014.06.014. Epub 2014 Jun 22.

PMID:
24963805
[PubMed - in process]
8.

Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.

Bielesz BO, Hecking M, Plischke M, Cejka D, Kieweg H, Haas M, Marculescu R, Hörl WH, Bieglmayer C, Sunder-Plassmann G.

Clin Biochem. 2014 Jun 21. pii: S0009-9120(14)00403-2. doi: 10.1016/j.clinbiochem.2014.06.009. [Epub ahead of print]

PMID:
24956265
[PubMed - as supplied by publisher]
9.

Health related quality of life in children with newly diagnosed immune thrombocytopenia.

Heitink-Pollé KM, Haverman L, Annink KV, Schep SJ, de Haas M, Bruin MC.

Haematologica. 2014 Jun 20. pii: haematol.2014.106963. [Epub ahead of print]

PMID:
24951468
[PubMed - as supplied by publisher]
Free Article
10.

A comparison of matched and aggregated group outcomes data for evaluating continuing education of hematology and oncology health care professionals.

Fagerlie SR, Heintz AA, Haas M, Stacy TB.

J Contin Educ Health Prof. 2014 Spring;34 Suppl 1:S23-9. doi: 10.1002/chp.21230.

PMID:
24935880
[PubMed - in process]
11.

Cost analysis related to dose-response of spinal manipulative therapy for chronic low back pain: outcomes from a randomized controlled trial.

Vavrek DA, Sharma R, Haas M.

J Manipulative Physiol Ther. 2014 Jun;37(5):300-11. doi: 10.1016/j.jmpt.2014.03.002.

PMID:
24928639
[PubMed - in process]
12.

Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn.

Kapur R, Della Valle L, Sonneveld M, Hipgrave Ederveen A, Visser R, Ligthart P, de Haas M, Wuhrer M, van der Schoot CE, Vidarsson G.

Br J Haematol. 2014 Jun 7. doi: 10.1111/bjh.12965. [Epub ahead of print]

PMID:
24909983
[PubMed - as supplied by publisher]
13.

Spinal manipulation and exercise for low back pain in adolescents: study protocol for a randomized controlled trial.

Schulz C, Leininger B, Evans R, Vavrek D, Peterson D, Haas M, Bronfort G.

Chiropr Man Therap. 2014 May 23;22:21. doi: 10.1186/2045-709X-22-21. eCollection 2014.

PMID:
24904748
[PubMed]
Free PMC Article
14.

Measuring static seated pressure distributions and risk for skin pressure ulceration in ice sledge hockey players.

Darrah SD, Dicianno BE, Berthold J, McCoy A, Haas M, Cooper RA.

Disabil Rehabil Assist Technol. 2014 May 29:1-6. [Epub ahead of print]

PMID:
24875641
[PubMed - as supplied by publisher]
15.

Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: A systematic review.

Langton JM, Blanch B, Drew AK, Haas M, Ingham JM, Pearson SA.

Palliat Med. 2014 May 27. pii: 0269216314533813. [Epub ahead of print] Review.

PMID:
24866758
[PubMed - as supplied by publisher]
16.

Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for acute myeloid leukaemia.

Fedele PL, Avery S, Patil S, Spencer A, Haas M, Wei A.

Intern Med J. 2014 Aug;44(8):757-63. doi: 10.1111/imj.12478.

PMID:
24863325
[PubMed - in process]
17.

Human equilibrative nucleoside transporter 1 is not predictive for gemcitabine efficacy in advanced pancreatic cancer: translational results from the AIO-PK0104 phase III study with the clone SP120 rabbit antibody.

Ormanns S, Heinemann V, Raponi M, Isaacson J, Laubender RP, Haas M, Kruger S, Kleespies A, Mann E, Bartosiewicz M, Kirchner T, Boeck S.

Eur J Cancer. 2014 Jul;50(11):1891-9. doi: 10.1016/j.ejca.2014.04.023. Epub 2014 May 20.

PMID:
24857044
[PubMed - in process]
18.

Trimethoprim-sulfamethoxazole for skin and soft tissue infections--let us not forget the risks.

Jenkins TC, Haas MK, Shihadeh KC, Lavonas EJ.

Ann Emerg Med. 2014 Jun;63(6):783-4. doi: 10.1016/j.annemergmed.2014.02.018. No abstract available.

PMID:
24841401
[PubMed - indexed for MEDLINE]
19.

TUBB5 and its disease-associated mutations influence the terminal differentiation and dendritic spine densities of cerebral cortical neurons.

Ngo L, Haas M, Qu Z, Li SS, Zenker J, Teng KS, Gunnersen JM, Breuss M, Habgood M, Keays DA, Heng JI.

Hum Mol Genet. 2014 May 15. pii: ddu238. [Epub ahead of print]

PMID:
24833723
[PubMed - as supplied by publisher]
20.

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial.

von Einem JC, Heinemann V, von Weikersthal LF, Vehling-Kaiser U, Stauch M, Hass HG, Decker T, Klein S, Held S, Jung A, Kirchner T, Haas M, Holch J, Michl M, Aubele P, Boeck S, Schulz C, Giessen C, Stintzing S, Modest DP.

J Cancer Res Clin Oncol. 2014 Sep;140(9):1607-14. doi: 10.1007/s00432-014-1678-3. Epub 2014 May 10.

PMID:
24816724
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk